Cargando…
Twenty Years After Glioblastoma Multiforme Diagnosis: A Case of Long-Term Survival
Glioblastoma multiforme (GBM) is an aggressive tumor that has a poor prognosis with a median survival of 15 months with treatment and 3-4 months without treatment. Subsets of patients are found to survive longer than two years, some survivors lived more than 10 years, and rare cases survived 20 year...
Autores principales: | Rabab'h, Omar, Al-Ramadan, Ali, Shah, Jawad, Lopez-Negrete, Hugo, Gharaibeh, Abeer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323618/ https://www.ncbi.nlm.nih.gov/pubmed/34345547 http://dx.doi.org/10.7759/cureus.16061 |
Ejemplares similares
-
Acute and Post-Acute Neurological Complications of COVID-19
por: Al-Ramadan, Ali, et al.
Publicado: (2021) -
Pharmacological Approaches in Neurofibromatosis Type 1-Associated Nervous System Tumors
por: Rabab’h, Omar, et al.
Publicado: (2021) -
Current Advances in Immunotherapy for Glioblastoma Multiforme and Future Prospects
por: Chowdhury, Selia, et al.
Publicado: (2021) -
CD133 Expression in Glioblastoma Multiforme: A Literature Review
por: Ahmed, Syed Ijlal, et al.
Publicado: (2018) -
Rising Incidence of Glioblastoma Multiforme in a Well-Defined Population
por: Grech, Neil, et al.
Publicado: (2020)